<DOC>
	<DOCNO>NCT00822003</DOCNO>
	<brief_summary>The investigator aim investigate pharmacokinetic pharmacodynamic effect single dose ( 2 mg ) oral GLP-1 administer prior oral glucose tolerance test ( oGTT ) 16 healthy male</brief_summary>
	<brief_title>Effects Oral GLP-1 Glucose Homeostasis Appetite Profile Healthy Male Subjects</brief_title>
	<detailed_description>Background : Glucagon like peptide-1 ( GLP-1 ) promote satiety reduces food intake . GLP-1 secrete intestinal L-cells splanchnic circulation , ( ) subject rapid breakdown ( ii ) submit high liver extraction . Highest concentration GLP-1 therefore find splanchnic blood rather systemic circulation . An oral delivery system would mimick physiological path endogenous secretion . Objective : We aim investigate pharmacokinetic pharmacodynamic effect single dose ( 2 mg ) oral GLP-1 administer prior oral glucose tolerance test ( oGTT ) 16 healthy male .</detailed_description>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<criteria>healthy male subject gastrointestinal endocrine disorder female alcohol drug abuse active virus hepatitis</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>GLP-1</keyword>
	<keyword>insulin</keyword>
	<keyword>glucose</keyword>
</DOC>